July 31, 2012
GlaxoSmithKline PLC and Pfizer Inc. on Tuesday failed to stop Hikma Pharmaceutical Co. Ltd. from selling a generic version of anti-coagulant Argatroban after a New Jersey federal judge ruled the company hadn't infringed a patent associated with the drug.